403 related articles for article (PubMed ID: 29573083)
1. Serum albumin level and abnormal corrected QT interval in patients with coronary artery disease and chronic kidney disease.
Wu CC; Lu YC; Yu TH; Wang CP; Hung WC; Tang WH; Tsai IT; Chung FM; Lee YJ; Hu JJ
Intern Med J; 2018 Oct; 48(10):1242-1251. PubMed ID: 29573083
[TBL] [Abstract][Full Text] [Related]
2. Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease.
Wang CP; Hsu CC; Hung WC; Yu TH; Wu CC; Tsai IT; Tang WH; Chung FM; Houng JY; Lee YJ; Lu YC
BMC Cardiovasc Disord; 2019 Jun; 19(1):153. PubMed ID: 31234795
[TBL] [Abstract][Full Text] [Related]
3. Serum total p-cresylsulfate level is associated with abnormal QTc interval in stable angina patients with early stage of renal failure.
Tang WH; Wang CP; Yu TH; Hung WC; Chung FM; Lu YC; Hsu CC; Lu LF; Huang LL; Lee YJ; Lai WT
Clin Chim Acta; 2014 Nov; 437():25-30. PubMed ID: 25011013
[TBL] [Abstract][Full Text] [Related]
4. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma fatty acid-binding protein 3 is related to prolonged corrected QT interval and reduced ejection fraction in patients with stable angina.
Lu YC; Lee TL; Hsuan CF; Hung WC; Wu CC; Wang CP; Wei CT; Yu TH; Chung FM; Lee YJ; Tsai IT
Int J Med Sci; 2021; 18(9):2076-2085. PubMed ID: 33850478
[No Abstract] [Full Text] [Related]
6. Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
Kim ED; Watt J; Tereshchenko LG; Jaar BG; Sozio SM; Kao WHL; Estrella MM; Parekh RS
BMC Nephrol; 2019 Apr; 20(1):133. PubMed ID: 30999887
[TBL] [Abstract][Full Text] [Related]
7. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study.
Chugh SS; Reinier K; Singh T; Uy-Evanado A; Socoteanu C; Peters D; Mariani R; Gunson K; Jui J
Circulation; 2009 Feb; 119(5):663-70. PubMed ID: 19171855
[TBL] [Abstract][Full Text] [Related]
8. Population-based study of QT interval prolongation in patients with rheumatoid arthritis.
Chauhan K; Ackerman MJ; Crowson CS; Matteson EL; Gabriel SE
Clin Exp Rheumatol; 2015; 33(1):84-9. PubMed ID: 25572282
[TBL] [Abstract][Full Text] [Related]
9. Coronary microvascular dysfunction is associated with baseline QTc prolongation amongst patients with chest pain and non-obstructive coronary artery disease.
Sara JD; Lennon RJ; Ackerman MJ; Friedman PA; Noseworthy PA; Lerman A
J Electrocardiol; 2016; 49(1):87-93. PubMed ID: 26620729
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Risk Factors and In-hospital Outcomes of QTc Interval Prolongation in Liver Cirrhosis.
Zhao J; Qi X; Hou F; Ning Z; Zhang X; Deng H; Peng Y; Li J; Wang X; Li H; Guo X
Am J Med Sci; 2016 Sep; 352(3):285-95. PubMed ID: 27650234
[TBL] [Abstract][Full Text] [Related]
11. Cardiac repolarization abnormalities among patients with various stages of chronic kidney disease.
Sherif KA; Abo-Salem E; Panikkath R; Nusrat M; Tuncel M
Clin Cardiol; 2014 Jul; 37(7):417-21. PubMed ID: 25043948
[TBL] [Abstract][Full Text] [Related]
12. Corrected QT-interval prolongation and variability in intensive care patients.
Hoogstraaten E; Rijkenberg S; van der Voort PH
J Crit Care; 2014 Oct; 29(5):835-9. PubMed ID: 24986247
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage.
Fukui S; Katoh H; Tsuzuki N; Ishihara S; Otani N; Ooigawa H; Toyooka T; Ohnuki A; Miyazawa T; Nawashiro H; Shima K
Crit Care; 2003 Jun; 7(3):R7-R12. PubMed ID: 12793884
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population.
Hung CS; Tseng PH; Tu CH; Chen CC; Liao WC; Lee YC; Chiu HM; Lin HJ; Ho YL; Yang WS; Wu MS; Chen MF
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26199227
[TBL] [Abstract][Full Text] [Related]
15. Effect of metabolic acidosis on QT intervals in patients with chronic kidney disease.
Yenigun EC; Aypak C; Turgut D; Aydin MZ; Dede F
Int J Artif Organs; 2016 Aug; 39(6):272-6. PubMed ID: 27515860
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.
Tisdale JE; Jaynes HA; Kingery JR; Mourad NA; Trujillo TN; Overholser BR; Kovacs RJ
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):479-87. PubMed ID: 23716032
[TBL] [Abstract][Full Text] [Related]
17. QTc Interval Prolongation Is Independently Associated with FGF23 and Predicts Mortality in Predialysis Chronic Kidney Disease.
Sikaneta T; Ho N; Bellasi A; Mahdavi S; Taskapan H; Svendrovski A; Makanjee B; Roberts J; Wu G; Nathoo B; Tam P
Cardiorenal Med; 2024; 14(1):45-57. PubMed ID: 37963445
[TBL] [Abstract][Full Text] [Related]
18. Effect of slow coronary flow on electrocardiographic parameters reflecting ventricular heterogeneity.
Sezgin AT; Barutcu I; Ozdemir R; Gullu H; Topal E; Esen AM; Tandogan I; Acikgoz N
Angiology; 2007; 58(3):289-94. PubMed ID: 17626982
[TBL] [Abstract][Full Text] [Related]
19. QTc prolongation prior to angiography predicts poor outcome and associates significantly with lower left ventricular ejection fractions and higher left ventricular end-diastolic pressures.
van der Bijl P; Heradien M; Doubell A; Brink P
Cardiovasc J Afr; 2012 Nov; 23(10):541-5. PubMed ID: 23192258
[TBL] [Abstract][Full Text] [Related]
20. A detailed description and assessment of outcomes of patients with hospital recorded QTc prolongation.
Laksman Z; Momciu B; Seong YW; Burrows P; Conacher S; Manlucu J; Leong-Sit P; Gula LJ; Skanes AC; Yee R; Klein GJ; Krahn AD
Am J Cardiol; 2015 Apr; 115(7):907-11. PubMed ID: 25665761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
